Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release

International Journal of Clinical Practice

Volumn 63, Issue 6, 2009, Pages 973-976

  Staskin, D R ^a   Cardozo, L ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TROSPIUM CHLORIDE; BENZILIC ACID DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DELAYED RELEASE FORMULATION; NORTROPANE DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERACTIVE BLADDER; PHASE 3 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE FORMULATION; TREATMENT OUTCOME; URINE INCONTINENCE; DELAYED RELEASE FORMULATION; DRUG ADMINISTRATION; MIDDLE AGED; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

BENZILATES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTROPANES; PARASYMPATHOLYTICS; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 65649127537     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02065.x     Document Type: Article

References (17)

1. Campbell UB, Stang P, Barron R. Survey assessment of continuation of and satisfaction with pharmacological treatment for urinary incontinence. Value Health 2007 11 : 726 32.
2. Landis JR, Kaplan S, Swift S, Versi E. Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity. J Urol 2004 171 : 752 6.
3. Millard RJ, Halaska M. Efficacy of solifenacin in patients with severe symptoms of overactive bladder: a pooled analysis. Curr Med Res Opin 2006 22 : 41 8.
4. Cardozo L, Castro-Diaz D, Gittelman M, Ridder A, Huang M. Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin. Int Urogynecol J Pelvic Floor Dysfunct 2006 17 : 512 9.
5. Dmochowski RR, Sand PK, Zinner NR, Staskin DR. Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study. Urology 2008 71 : 449 54.
6. Staskin D, Sand P, Zinner N, Dmochowski R. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial. J Urol 2007 178 : 978 83, discussion 83-4.
7. Chapple CR, Cardozo L, Steers WD, Govier FE. Solifenacin significantly improves all symptoms of overactive bladder syndrome. Int J Clin Pract 2006 60 : 959 66.
8. Wein AJ, Dmochowski RR. Strategies for data comparison for drugs used in the treatment of overactive bladder. In : Kreder K, Dmochowski R, eds. The Overactive Bladder: Evaluation and Management. London : Informa Healthcare, 2007 : 239 52.
9. MacDiarmid S, Rosenberg M. Overactive bladder in women: symptom impact and treatment expectations. Curr Med Res Opin 2005 21 : 1413 21.
10. Levy R, Muller N. Urinary incontinence: economic burden and new choices in pharmaceutical treatment. Adv Ther 2006 23 : 556 73.
11. Diokno A, Lee P, Zorn BH et al. Factors associated with clinical assessment of overactive bladder and selection of treatment. Clin Ther 2001 23 : 1542 51.
12. Irwin DE, Milsom I, Kopp Z, Abrams P. Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol 2008 53 : 1029 37.
13. Li Y, Cai X, Glance LG, Mukamel DB. Gender differences in healthcare-seeking behavior for urinary incontinence and the impact of socioeconomic status: a study of the Medicare managed care population. Med Care 2007 45 : 1116 22.
14. Koch LH. Help-seeking behaviors of women with urinary incontinence: an integrative literature review. J Midwifery Womens Health 2006 51 : e39 44.
15. Coyne KS, Zhou Z, Thompson C, Versi E. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 2003 92 : 731 5.
16. Mardon RE, Halim S, Pawlson LG, Haffer SC. Management of urinary incontinence in Medicare managed care beneficiaries: results from the 2004 Medicare Health Outcomes Survey. Arch Intern Med 2006 166 : 1128 33.
17. Harris SS, Link CL, Tennstedt SL, Kusek JW, McKinlay JB. Care seeking and treatment for urinary incontinence in a diverse population. J Urol 2007 177 : 680 4.